100 related articles for article (PubMed ID: 18336955)
1. No association of DAPK1 and ABCA2 SNPs on chromosome 9 with Alzheimer's disease.
Minster RL; DeKosky ST; Kamboh MI
Neurobiol Aging; 2009 Nov; 30(11):1890-1. PubMed ID: 18336955
[TBL] [Abstract][Full Text] [Related]
2. DAPK1 variants are associated with Alzheimer's disease and allele-specific expression.
Li Y; Grupe A; Rowland C; Nowotny P; Kauwe JS; Smemo S; Hinrichs A; Tacey K; Toombs TA; Kwok S; Catanese J; White TJ; Maxwell TJ; Hollingworth P; Abraham R; Rubinsztein DC; Brayne C; Wavrant-De Vrièze F; Hardy J; O'Donovan M; Lovestone S; Morris JC; Thal LJ; Owen M; Williams J; Goate A
Hum Mol Genet; 2006 Sep; 15(17):2560-8. PubMed ID: 16847012
[TBL] [Abstract][Full Text] [Related]
3. Family-based association between Alzheimer's disease and variants in UBQLN1.
Bertram L; Hiltunen M; Parkinson M; Ingelsson M; Lange C; Ramasamy K; Mullin K; Menon R; Sampson AJ; Hsiao MY; Elliott KJ; Velicelebi G; Moscarillo T; Hyman BT; Wagner SL; Becker KD; Blacker D; Tanzi RE
N Engl J Med; 2005 Mar; 352(9):884-94. PubMed ID: 15745979
[TBL] [Abstract][Full Text] [Related]
4. Association of DAPK1 genetic variations with Alzheimer's disease in Han Chinese.
Wu ZC; Zhang W; Yu JT; Zhang Q; Tian Y; Lu RC; Yu NN; Chi ZF; Tan L
Brain Res; 2011 Feb; 1374():129-33. PubMed ID: 21167819
[TBL] [Abstract][Full Text] [Related]
5. DAPK1 is associated with FTD and not with Alzheimer's disease.
Tedde A; Piaceri I; Bagnoli S; Lucenteforte E; Piacentini S; Sorbi S; Nacmias B
J Alzheimers Dis; 2012; 32(1):13-7. PubMed ID: 22785394
[TBL] [Abstract][Full Text] [Related]
6. Identification of a late onset Alzheimer's disease candidate risk variant at 9q21.33 in Polish patients.
Gaj P; Paziewska A; Bik W; Dąbrowska M; Baranowska-Bik A; Styczynska M; Chodakowska-Żebrowska M; Pfeffer-Baczuk A; Barcikowska M; Baranowska B; Ostrowski J
J Alzheimers Dis; 2012; 32(1):157-68. PubMed ID: 22785395
[TBL] [Abstract][Full Text] [Related]
7. ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease.
Macé S; Cousin E; Ricard S; Génin E; Spanakis E; Lafargue-Soubigou C; Génin B; Fournel R; Roche S; Haussy G; Massey F; Soubigou S; Bréfort G; Benoit P; Brice A; Campion D; Hollis M; Pradier L; Benavides J; Deleuze JF
Neurobiol Dis; 2005 Feb; 18(1):119-25. PubMed ID: 15649702
[TBL] [Abstract][Full Text] [Related]
8. Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease.
Sundar PD; Feingold E; Minster RL; DeKosky ST; Kamboh MI
Neurobiol Aging; 2007 Jun; 28(6):856-62. PubMed ID: 16725228
[TBL] [Abstract][Full Text] [Related]
9. Ubiquilin 1 polymorphisms are not associated with late-onset Alzheimer's disease.
Smemo S; Nowotny P; Hinrichs AL; Kauwe JS; Cherny S; Erickson K; Myers AJ; Kaleem M; Marlowe L; Gibson AM; Hollingworth P; O'Donovan MC; Morris CM; Holmans P; Lovestone S; Morris JC; Thal L; Li Y; Grupe A; Hardy J; Owen MJ; Williams J; Goate A
Ann Neurol; 2006 Jan; 59(1):21-6. PubMed ID: 16278862
[TBL] [Abstract][Full Text] [Related]
10. The UBQLN1 polymorphism, UBQ-8i, at 9q22 is not associated with Alzheimer's disease with onset before 70 years.
Brouwers N; Sleegers K; Engelborghs S; Bogaerts V; van Duijn CM; De Deyn PP; Van Broeckhoven C; Dermaut B
Neurosci Lett; 2006 Jan; 392(1-2):72-4. PubMed ID: 16214290
[TBL] [Abstract][Full Text] [Related]
11. Rs4878104 contributes to Alzheimer's disease risk and regulates DAPK1 gene expression.
Hu Y; Cheng L; Zhang Y; Bai W; Zhou W; Wang T; Han Z; Zong J; Jin S; Zhang J; Jiang Q; Liu G
Neurol Sci; 2017 Jul; 38(7):1255-1262. PubMed ID: 28429084
[TBL] [Abstract][Full Text] [Related]
12. Ethnicity-dependent genetic association of ABCA2 with sporadic Alzheimer's disease.
Wollmer MA; Kapaki E; Hersberger M; Muntwyler J; Brunner F; Tsolaki M; Akatsu H; Kosaka K; Michikawa M; Molyva D; Paraskevas GP; Lütjohann D; von Eckardstein A; Hock C; Nitsch RM; Papassotiropoulos A
Am J Med Genet B Neuropsychiatr Genet; 2006 Jul; 141B(5):534-6. PubMed ID: 16752360
[TBL] [Abstract][Full Text] [Related]
13. Association of UBQ-8i polymorphism with Alzheimer's disease in Caucasians: a meta-analysis.
Yue Z; Wang S; Yan W; Zhu F
Int J Neurosci; 2015 Jun; 125(6):395-401. PubMed ID: 25010605
[TBL] [Abstract][Full Text] [Related]
14. Death-associated protein kinase 1 variation and Parkinson's disease.
Dachsel JC; Wider C; Vilariño-Güell C; Aasly JO; Rajput A; Rajput AH; Lynch T; Craig D; Krygowska-Wajs A; Jasinska-Myga B; Opala G; Barcikowska M; Czyzewski K; Wu RM; Heckman MG; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
Eur J Neurol; 2011 Aug; 18(8):1090-3. PubMed ID: 21749573
[TBL] [Abstract][Full Text] [Related]
15. No association of dynamin binding protein (DNMBP) gene SNPs and Alzheimer's disease.
Minster RL; DeKosky ST; Kamboh MI
Neurobiol Aging; 2008 Oct; 29(10):1602-4. PubMed ID: 17442457
[TBL] [Abstract][Full Text] [Related]
16. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
[TBL] [Abstract][Full Text] [Related]
17. Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures.
Kamboh MI; Minster RL; Feingold E; DeKosky ST
Mol Psychiatry; 2006 Mar; 11(3):273-9. PubMed ID: 16302009
[TBL] [Abstract][Full Text] [Related]
18. Lack of association between UBQLN1 and Alzheimer disease.
Slifer MA; Martin ER; Bronson PG; Browning-Large C; Doraiswamy PM; Welsh-Bohmer KA; Gilbert JR; Haines JL; Pericak-Vance MA
Am J Med Genet B Neuropsychiatr Genet; 2006 Apr; 141B(3):208-13. PubMed ID: 16526030
[TBL] [Abstract][Full Text] [Related]
19. Extremely rare incidence of the UBQLN1 polymorphism (UBQ-8i) in Taiwan Chinese with Alzheimer's disease.
Chuo LJ; Wu ST; Chang HI; Kuo YM
Neurosci Lett; 2010 May; 475(2):108-9. PubMed ID: 20350585
[TBL] [Abstract][Full Text] [Related]
20. A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy.
Kiyotani K; Uno S; Mushiroda T; Takahashi A; Kubo M; Mitsuhata N; Ina S; Kihara C; Kimura Y; Yamaue H; Hirata K; Nakamura Y; Zembutsu H
Pharmacogenet Genomics; 2012 Apr; 22(4):229-35. PubMed ID: 22293537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
